Beranda › Gangguan Pendengaran › Maryland
Uji klinis Gangguan Pendengaran di Maryland
8 studi untuk Gangguan Pendengaran mencari peserta di lokasi di Maryland.
Kota di Maryland
Teks studi resmi (Bahasa Inggris)
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
- Johns Hopkins University, Baltimore
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05730283NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 3 hingga 99 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06303180Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- University of Maryland Medical Center, Baltimore
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT04915183Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
- National Institutes of Health-Clinical Center, Bethesda
Menerima pesertaFase 1/2
9 Months – 7 Years · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07627971Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasional
Usia 2 hingga 99 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT05670496Natural History of Autosomal Dominant Hearing Loss
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 3 hingga 99 · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT04501081Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
- Johns Hopkins Hospital, Baltimore
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT06517888HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
- Johns Hopkins Memory and Alzheimer's Treatment Center, Baltimore
Menerima pesertaSukarelawan sehat diterima
Usia 60 hingga 100 · Semua jenis kelamin · Diperbarui 24 Nov 2025 · NCT06930560Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.